Enter multiple symbols separated by commas

Merck Says Fourth-quarter Profit Rose 18% on Sales of Erbitux

German drugmaker Merck said Thursday its fourth-quarter profit rose 18% after the company boosted sales of its Erbitux cancer treatment.

Net income rose to 129.5 million euros ($167.4 million) in the three months through Dec. 31 from 109.5 million euros in the same period a year earlier, the company said in a statement. Sales climbed 8.5% to 1.63 billion euros.

"As the above numbers are preliminary figures and because it is still very early in the year, it is too soon to discuss a dividend for 2006 or an outlook for 2007," the company said.

Sales of Erbitux rose 55% to 337 million euros ($435.6 million). Merck sells Erbitux in Europe, while Bristol-Myers Squibb Inc. sells Erbitux in the United States and Canada.

Merck shares gained 0.9% to 90.37 euros ($116.82) in Frankfurt.

Darmstadt-based Merck's other products include the cardiovascular treatment Concor. Merck also recently completed its 10.6 billion euros ($13.9 billion) acquisition of Swiss biotech company Serono, aimed at expanding its range of drugs and share of the global biotechnology market.

Merck, founded as a pharmacy in 1668, is the oldest pharmaceutical business in the world. It has been entirely separate from New Jersey-based Merck & Co. since the end of World War I and employs some 29,000 people.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Hero miles for military members: Real estate magnate's plea

    Chairman of the Fisher House Foundation, Ken Fisher, discusses the Hero Miles program with CNBC's Dina Gusovsky. During Military Appreciation Month, Fisher is asking every traveler to donate 1,000 of their miles to replenish the Hero Miles programs that is in danger of running out.

  • Cramer shuts down this market's haters

    "Mad Money" host Jim Cramer on why this market can't stop, won't stop.

  • From the battlefield to the boardroom

    Your Grateful Nation is dedicated to helping Special Forces veterans enter the corporate world and Knot Standard provides complimentary suits to vets. Mad Money's Jim Cramer spoke with Rob Clapper, Your Grateful executive director; John Ballay, Knot Standard co-founder and president; Tej Gill, retired U.S. Navy Seal; and Darren McB, active duty U.S. Navy Seal.